Structure Therapeutics, Inc. (GPCR)
69.55
+1.77
(+2.61%)
USD |
NASDAQ |
Dec 31, 16:00
70.01
+0.46
(+0.66%)
Pre-Market: 08:24
Structure Therapeutics EPS Diluted (Quarterly): -1.125 for Sept. 30, 2025
EPS Diluted (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| Eli Lilly & Co. | 6.211 |
| Novo Nordisk A/S | 0.7044 |
| Pfizer Inc. | 0.6197 |
| Viking Therapeutics, Inc. | -0.8083 |
| Terns Pharmaceuticals, Inc. | -0.2686 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | -65.80M |
| Total Expenses (Quarterly) | 65.80M |
| Enterprise Value | 3.214B |
| Earnings Yield | -5.25% |
| Normalized Earnings Yield | -5.252 |